Topotecan Using Convection-Enhanced Delivery (CED) in High Grade Glioma

Clinical trial NCT02278510 · COMPLETED

Trial details

NCT number: NCT02278510
Sponsor: Michael Vogelbaum, MD, PhD
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Malignant Glioma WHO Grade III or IV Recurrent Glioma

Start date: 2014-12-09
Primary completion: 2015-11-10
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.